{"id":"NCT02545504","sponsor":"Gilead Sciences","briefTitle":"Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma","officialTitle":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5745 Combined With mFOLFOX6 as First Line Treatment in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-10-13","primaryCompletion":"2019-05-15","completion":"2019-05-15","firstPosted":"2015-09-10","resultsPosted":"2020-04-28","lastUpdate":"2020-05-26"},"enrollment":432,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Gastric Adenocarcinoma"],"interventions":[{"type":"DRUG","name":"Andecaliximab","otherNames":["GS-5745"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Leucovorin","otherNames":["LV"]},{"type":"DRUG","name":"5-fluorouracil","otherNames":["5-FU"]},{"type":"DRUG","name":"Oxaliplatin","otherNames":["OXA"]}],"arms":[{"label":"Andecaliximab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to compare the efficacy of andecaliximab (GS-5745) versus placebo in combination with modified fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (OXA) (mFOLFOX6) as measured by overall survival.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"Andecaliximab + mFOLFOX6 median follow-up at the time of final analysis: 19.43 months; Placebo + mFOLFOX6 median follow-up at the time of the final analysis: 19.45 months","effectByArm":[{"arm":"Andecaliximab + mFOLFOX6","deltaMin":12.52,"sd":null},{"arm":"Placebo + mFOLFOX6","deltaMin":11.76,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.5625"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":134,"countries":["United States","Australia","Belgium","Chile","Colombia","Czechia","France","Germany","Hungary","Italy","Peru","Poland","Romania","Spain","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["33577358"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":103,"n":216},"commonTop":["Nausea","Diarrhoea","Fatigue","Neutropenia","Peripheral sensory neuropathy"]}}